Kyle Guse, CFO, Gen Counsel and Secretary at Atossa Therapeutics, holds 10.00K shares in Atossa Therapeutics (Ticker: ATOS). Most recently, Kyle Guse Bought $10,000 shares of Atossa Therapeutics on Nov 16, 2017 for an estimated value of 3.30K.
What is the percentage of profitable transactions made by Kyle Guse?
The percentage of profitable transactions made by Kyle Guse is ―.
What is the average return per transaction made by Kyle Guse?
The average return per transaction made by Kyle Guse is ―.
What stocks does Kyle Guse hold?
Kyle Guse holds: ATOS stocks.
What was Kyle Guse’s latest transaction?
Kyle Guse latest transaction was an Informative Buy of $3.30K.
What was Kyle Guse's most profitable transaction?
Kyle Guse’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kyle Guse's role in Atossa Therapeutics?
Kyle Guse's role in Atossa Therapeutics is CFO, Gen Counsel and Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.